Patrick Doherty, MD
Neurological Surgery · New London, CTNPI 1578620282
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.9%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Royal Biologics, Inc. at 33.4% of the total. Reporting peaked in 2019 at $21,259 and has fallen 60.0% since, to $8,511 in 2025.
Across 182 payments — averaging $394.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Royal Biologics, Inc.$24K
- Spineart SA$16K
- Globus Medical$14K
- Kuros Biosciences USA, Inc$7K
- Atlas Spine, Inc.$6K
- Spineart USA Inc$649
- plus $4K from 20 others
Across 11 payments — averaging $3655.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$40K
What the payments were for
- Royalty or licence$19,86828%
- Consulting fees$29,34841%
- Speaking & faculty fees$5001%
- Travel & lodging$13,53619%
- Food & beverage$8,58812%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Royal Biologics, Inc. | 32 | $23,987 |
| Spineart SA | 4 | $16,134 |
| Globus Medical | 80 | $14,143 |
| Kuros Biosciences USA, Inc | 8 | $6,742 |
| Atlas Spine, Inc. | 7 | $6,286 |
| Spineart USA Inc | 3 | $649 |
| Spineology Inc. | 2 | $445 |
| Abbott | 6 | $421 |
| Medtronic(2 entities) | 8 | $420 |
| Integrity Implants Inc. | 5 | $417 |
| Si-bone, Inc. | 3 | $358 |
| Alphatec Spine, Inc | 1 | $345 |
| Biocomposites Inc | 3 | $328 |
| Stryker | 4 | $245 |
| Integrity Implants Inc. Dba Accelus | 3 | $211 |
| Lenoss Medical Inc | 2 | $150 |
| Orthofix Medical, Inc. | 2 | $126 |
| Boston Scientific | 1 | $125 |
| Benvenue Medical Inc | 1 | $90 |
| Vertos Medical, Inc. | 1 | $89 |
| Nevro Corp. | 1 | $26 |
| Lemaitre Vascular, Inc. | 1 | $24 |
| AbbVie | 1 | $24 |
| Spinal Simplicity, LLC | 1 | $22 |
| Theragen, Inc. | 1 | $18 |
| Paradigm Spine, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fibrinet$13,852
- Romeo 2 PAD$9,318
- Romeo PAD$6,816
- MagnetOs$6,536
- HiJAK AC$6,200
- Excelsius - GPS$3,747
- CREO MIS Stabilization System$2,908
- ExcelsiusGPS Robotic Navigation System$2,216
- EXCELSIUS$1,134
- ELSA$802
- Excelsius Robotics System$620
- OptiMesh Interbody Fusion System$399
- INVICTUS OPEN$345
- ELSA ATP$299
- Stimulan$265
- Excelsius Deformity$171
- NVM5$165
- COALITION AGX$160
- Axium INS DRG IPG$155
- RISE-L$152
How this compares
$71,840 in reported general payments places this provider in the 85th percentile of 94 neurological surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclobenzaprine Hcl | 107 | $817 |
| Celecoxib | 23 | $671 |
| Pregabalin | 28 | $619 |
| Oxycodone Hcl | 103 | $581 |
| Diclofenac Sodium | 18 | $564 |
| Gabapentin | 45 | $477 |
| Baclofen | 26 | $382 |
| Tizanidine Hcl | 19 | $373 |
| Methocarbamol | 23 | $257 |
| Methylprednisolone | 34 | $254 |
| Mupirocin | 28 | $238 |
| Tramadol Hcl | 30 | $141 |
| Meloxicam | 14 | $36 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in New London
- Murat GunelNew Haven$839K
- Sanjay RathiNorth Haven$541K
- Patrick SenatusSouth Windsor$309K
- Ahmed KhanNew Britain$250K
- Abraham MintzShelton$204K
- Joshua MarcusDanbury$142K
- Pooia FattahiMiddlebury$140K
- Pedro de Oliveira CoutinhoNew Haven$129K
- Ehud MendelNew Haven$120K
- Charles MatoukNew Haven$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.